Efficacy of two types of palliative sedation therapy defined using intervention protocols: proportional vs. deep sedation

被引:30
作者
Imai, Kengo [1 ]
Morita, Tatsuya [2 ]
Yokomichi, Naosuke [1 ]
Mori, Masanori [3 ]
Naito, Akemi Shirado [1 ]
Tsukuura, Hiroaki [1 ]
Yamauchi, Toshihiro [1 ]
Kawaguchi, Takashi [4 ]
Fukuta, Kaori [5 ]
Inoue, Satoshi [1 ]
机构
[1] Seirei Mikatahara Gen Hosp, Seirei Hosp, Kita Ku, 3453 Mikatahara Cho, Hamamatsu, Shizuoka 4338558, Japan
[2] Seirei Mikatahara Gen Hosp, Div Palliat & Support Care, Hamamatsu, Shizuoka, Japan
[3] Seirei Mikatahara Gen Hosp, Palliat Care Team, Hamamatsu, Shizuoka, Japan
[4] Tokyo Univ Pharm & Life Sci, Dept Pract Pharm, Tokyo, Japan
[5] Seirei Mikatahara Gen Hosp, Dept Nursing, Hamamatsu, Shizuoka, Japan
关键词
Palliative sedation therapy; Intervention protocol; Continuous infusion of midazolam; Proportional sedation; Deep sedation; Definition; CLINICAL-PRACTICE GUIDELINES; TARGET CONTROLLED INFUSION; UNTIL DEATH; CARE; MIDAZOLAM; END; RELIABILITY; LIFE; PHARMACODYNAMICS; PHARMACOKINETICS;
D O I
10.1007/s00520-017-4011-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study investigated the effect of two types of palliative sedation defined using intervention protocols: proportional and deep sedation. We retrospectively analyzed prospectively recorded data of consecutive cancer patients who received the continuous infusion of midazolam in a palliative care unit. Attending physicians chose the sedation protocol based on each patient's wish, symptom severity, prognosis, and refractoriness of suffering. The primary endpoint was a treatment goal achievement at 4 h: in proportional sedation, the achievement of symptom relief (Support Team Assessment Schedule (STAS) ae 1) and absence of agitation (modified Richmond Agitation-Sedation Scale (RASS) ae> 0) and in deep sedation, the achievement of deep sedation (RASS ae - 4). Secondary endpoints included mean scores of STAS and RASS, deep sedation as a result, and adverse events. Among 398 patients who died during the period, 32 received proportional and 18 received deep sedation. The treatment goal achievement rate was 68.8% (22/32, 95% confidence interval 52.7-84.9) in the proportional sedation group vs. 83.3% (15/18, 66.1-100) in the deep sedation group. STAS decreased from 3.8 to 0.8 with proportional sedation at 4 h vs. 3.7 to 0.3 with deep sedation; RASS decreased from + 1.2 to - 1.7 vs. + 1.4 to - 3.7, respectively. Deep sedation was needed as a result in 31.3% (10/32) of the proportional sedation group. No fatal events that were considered as probably or definitely related to the intervention occurred. The two types of intervention protocol well reflected the treatment intention and expected outcomes. Further, large-scale cohort studies are promising.
引用
收藏
页码:1763 / 1771
页数:9
相关论文
共 34 条
[1]   The effect of age on the pharmacokinetics and pharmacodynamics of midazolam [J].
Albrecht, S ;
Ihmsen, H ;
Hering, W ;
Geisslinger, G ;
Dingemanse, J ;
Schwilden, H ;
Schüttler, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (06) :630-639
[2]   Appropriateness and Reliability Testing of the Modified Richmond Agitation-Sedation Scale in Spanish Patients With Advanced Cancer [J].
Angel Benitez-Rosario, Miguel ;
Castillo-Padros, Manuel ;
Garrido-Bernet, Belen ;
Gonzalez-Guillermo, Toribio ;
Pedro Martinez-Castillo, Luis ;
Gonzalez, Aceysele .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2013, 45 (06) :1112-1119
[3]   Palliative pharmacological sedation for terminally ill adults [J].
Beller, E. M. ;
van Driel, M. L. ;
McGregor, L. ;
Truong, S. ;
Mitchell, G. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (01)
[4]   Midazolam therapeutic drug monitoring in intensive care sedation -: A 5-year survey [J].
Bremer, F ;
Reulbach, U ;
Schwilden, H ;
Schüttler, J .
THERAPEUTIC DRUG MONITORING, 2004, 26 (06) :643-649
[5]   Measuring patient outcomes in palliative care: a reliability and validity study of the Support Team Assessment Schedule [J].
Carson, MG ;
Fitch, MI ;
Vachon, MLS .
PALLIATIVE MEDICINE, 2000, 14 (01) :25-36
[6]   ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation [J].
Cherny, N. I. .
ANNALS OF ONCOLOGY, 2014, 25 :143-152
[7]   European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care [J].
Cherny, Nathan I. ;
Radbruch, Lukas .
PALLIATIVE MEDICINE, 2009, 23 (07) :581-593
[8]   Palliative sedation: A review of the research literature [J].
Claessens, Patricia ;
Menten, Johan ;
Schotsmans, Paul ;
Broeckaert, Bert .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2008, 36 (03) :310-333
[9]   Palliative sedation therapy in the last weeks of life: A literature review and recommendations for standards [J].
De Graeff, Alexander ;
Dean, Mervyn .
JOURNAL OF PALLIATIVE MEDICINE, 2007, 10 (01) :67-85
[10]   Framework for Continuous Palliative Sedation Therapy in Canada [J].
Dean, Mervyn M. ;
Cellarius, Victor ;
Henry, Blair ;
Oneschuk, Doreen ;
Librach, Lawrence .
JOURNAL OF PALLIATIVE MEDICINE, 2012, 15 (08) :870-879